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Outcomes of tunneled femoral hemodialysis catheters: Com-
parison with internal jugular vein catheters.
Background. Tunneled femoral vein dialysis catheters are
used as a last resort when all other options for a permanent
vascular access or thoracic central vein catheter have been ex-
hausted. There is little published literature on the complications
or outcomes of tunneled femoral catheters.
Methods. Using a prospective, computerized vascular access
database, we identified all tunneled femoral dialysis catheters
placed at the University of Alabama at Birmingham during a
five-year period. The clinical features, catheter patency, and
complications in these patients were compared to those ob-
served in a group of sex-, age-, and date-matched control pa-
tients with tunneled internal jugular vein dialysis catheters.
Results. During the study period, 27 patients received a
tunneled femoral dialysis catheter, accounting for 1.9% of all
tunneled catheters placed. Only 7 patients (26%) were able
to convert to a new permanent dialysis access. The primary
catheter patency (time from placement to exchange) was sub-
stantially shorter for femoral catheters than for internal jugu-
lar dialysis catheters (median survival, 59 vs. >300 days, P <
0.0001). Infection-free survival was similar for both groups (P =
0.66). Seven patients with femoral catheters (or 26%) devel-
oped an ipsilateral deep vein thrombosis, but catheter use was
possible with anticoagulation.
Conclusion. Tunneled femoral dialysis catheters have a sub-
stantially shorter primary patency, but a similar risk of catheter-
related bacteremia, as compared with internal jugular vein
catheters. An ipsilateral lower extremity deep vein thrombosis
occurs commonly after placement of a femoral dialysis catheter,
but does not preclude continued catheter use.
Tunneled hemodialysis catheters are used for tempo-
rary vascular access in patients awaiting placement or
maturation of a permanent vascular access (A-V fistula
or graft) [1]. They are also required for long-term access
in patients who have exhausted all options for placement
of a permanent access in all four extremities [2]. Tunneled
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dialysis catheters are usually placed in a central vein in
the chest, most commonly in the internal jugular vein,
and less commonly in the subclavian vein [3]. However,
when prolonged use of upper extremity dialysis catheters
leads to bilateral occlusion of the central veins, it becomes
necessary to place a tunneled catheter in the femoral vein
[4, 5]. Due to their proximity to the groin, one would an-
ticipate that femoral vein catheters would be more prone
than internal jugular vein catheters to problems with low
dialysis blood flows, loss of patency, and catheter-related
bacteremia. However, there is only a single published se-
ries addressing this problem [6].
We have been maintaining a prospective, computerized
database of all vascular access procedures performed at
our institution. Using this database, we have identified all
tunneled femoral hemodialysis catheters placed during a
five-year period [7]. The present study evaluated the out-
comes and complication of these catheters, and compared
them to a group of matched control patients receiving an
internal jugular vein dialysis catheter.
METHODS
Study population
The University of Alabama at Birmingham (UAB)
provides medical care for approximately 500 hemodialy-
sis patients, under the supervision of 12 full-time nephrol-
ogists. Three transplant surgeons perform all the vascular
access surgical procedures. Three interventional radiol-
ogists and one interventional nephrologist perform all
the radiologic vascular access intervention. Over 95%
of all hospitalizations of our dialysis patients occur at
UAB Hospital, allowing for comprehensive follow-up of
any complications. Finally, two full-time access coordi-
nators hired by the Division of Nephrology schedule all
access procedures and maintain a prospective, computer-
ized database of all vascular access procedures [7].
Procedures
All tunneled, cuffed femoral, or internal jugular vein
catheters were placed by an interventional nephrologist
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or radiologist or by a transplant surgeon. The catheter
placements were performed under real-time ultrasound
and fluoroscopic guidance either in a fluoroscopy suite or
in the operating room. We used 14.5 French Ash-Split per-
manent hemodialysis catheters with lengths from 24 cm
for right internal jugular, 28 cm for left internal jugu-
lar, and from 36 to 42 cm for femoral veins. We also used
15 French Dura-Flow and Hemo-Split catheters with sim-
ilar lengths. These techniques have been published previ-
ously [4, 8]. The tip of the catheter was placed in the right
atrium for internal jugular catheters, and in the proximal
inferior vena cava for femoral catheters. The skin exit
site for the tunneled femoral catheters was in the lateral
thigh, 5 to 7 cm inferior to the iliofemoral line.
Catheters were instilled with recombinant tissue plas-
minogen activator (Altaplase; Genentech, South San
Francisco, CA, USA), 2 mg per port, if they could not
deliver a dialysis blood flow of at least 250 mL/min [9]. If
the tPA instillation failed to improve the blood flow, the
catheter was exchanged for a new one over a guidewire
in the fluoroscopy suite. Catheter-related bacteremia was
suspected if the patient developed fever or chills. After
obtaining blood cultures, the patient was started on sys-
temic antibiotics, in conjunction with an antibiotic lock
protocol [10, 11]. Patients with persistent fever or posi-
tive surveillance blood cultures despite the antibiotic lock
protocol were scheduled for catheter exchange.
Data analysis
The prospective, computerized database was used to
identify all tunneled cuffed dialysis catheters placed
during the five-year period from January 1, 2000 to
December 31, 2004. We identified 27 patients who re-
ceived a tunneled femoral dialysis catheter. For each of
these patients, we selected two age- and sex-matched con-
trol patients receiving tunneled internal jugular catheters
during the same time period (within 8 days of the femoral
catheter placement). Permission was obtained from the
UAB Institutional Review Board to review each patient’s
medical records for research purposes.
Demographic and clinical information collected in-
cluded patient age, sex, race, and comorbidity. In ad-
dition, the access database was analyzed to determine
the date of first catheter exchange, first episode of
catheter-related bacteremia, and any other catheter-
related complications. Catheter survival (primary pa-
tency) was calculated from date of catheter placement
to the date of the first catheter exchange. Infection-free
survival was calculated from the date of catheter place-
ment to the first episode of catheter-related bacteremia
(regardless of catheter exchange due to loss of patency).
Follow-up was censored for of death, change of dialysis
modality, transfer to another facility, or elective catheter
removal.
Table 1. Baseline characteristics of the study patients
Parameter Fem catheter IJ catheter P value
N pts 27 54
Age 52 ± 13 55 ± 12 0.25
Race N (% black) 24 (92.3%) 40 (74.1%) 0.06
Sex N (% male) 11 (40.7%) 22 (40.7%) 1.00
Diabetes N (%) 9 (34.6%) 25 (46.3%) 0.32
Hypertension N (%) 24 (92.3%) 46 (85.2%) 0.37
CAD N (%) 9 (34.6%) 11 (20.4%) 0.17
PVD 2 (7.7%) 10 (18.5%) 0.20
Years on HD 4.1 ± 3.4 1.8 ± 2.8 0.0015
Statistical analysis
Baseline patient characteristics were compared be-
tween the patients with tunneled femoral catheters
and those with internal jugular catheters using Student
t tests or Chi-square analysis. Survival curves for primary
catheter patency and infection-free survival were gener-
ated using Kaplan-Meier methodology, and the differ-
ences between groups analyzed by the log rank test.
RESULTS
During the five-year study time period, a total of 1489
new tunneled dialysis catheters were placed. Of these, 27
catheters (or 1.8% of the total) were placed in the femoral
vein. The clinical characteristics of the patients receiving
tunneled femoral catheters and the matched controls re-
ceiving internal jugular catheters are compared in Table 1.
The two groups were similar in age, sex, race, diabetic
status, and comorbidity. As expected, the patients with
femoral catheters had been on dialysis over two years
longer than the matched control patients. Prior to receiv-
ing a tunneled femoral catheter, the patients had had an
average of 4.3 ± 2.5 permanent vascular accesses.
Among the 27 patients receiving a tunneled femoral
catheter, only seven (or 26%) subsequently received a
new access. Four received a peritoneal dialysis catheter,
two a thigh graft, and one an upper arm graft (after re-
canalization of the central vein). The remaining patients
remained dependent on their femoral catheter for vascu-
lar access until their death or the end of study follow-up.
The primary catheter patency (time from initial place-
ment to first exchange) was substantially shorter for tun-
neled femoral catheters than for those in the internal
jugular vein (Fig. 1). Catheter survival was 71 versus 90%
at 30 days, 43 versus 81% at 60 days, 33 versus 78 at
90 days, and 14 versus 67% at 180 days. The median
femoral catheter survival was 59 days, compared with
>300 days for the internal jugular catheters. Among 21
patients requiring exchange of a femoral dialysis catheter,
15 (71%) were due to persistent low blood flows and six
(29%) due to refractory infection. Among 13 patients re-
quiring exchange of an internal jugular catheter, 11 (85%)
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Fig. 1. Primary patency (time from initial placement to first exchange)
of tunneled dialysis catheters placed in the femoral vein (solid line) and
internal jugular vein (dashed line). P < 0.0001 by the log rank test.
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Fig. 2. Infection-free survival (time from catheter placement to first
episode of catheter-related bacteremia) of tunneled dialysis catheters
placed in the femoral vein (solid line) and internal jugular vein (dashed
line). Infection-free survival was calculated independently of need for
catheter exchange due to malfunction. P = 0.66 by the log rank test.
were due to persistent flow problems and two (15%) due
to refractory infection.
The infection-free survival was similar for both patient
groups, with a cumulative incidence of catheter-related
bacteremia of ∼40% after five months (Fig. 2). The blood
cultures grew a wide variety of Gram-positive and Gram-
negative organisms, but the distribution did not differ
between patients with femoral and internal jugular vein
dialysis catheters.
Seven of the 27 patients (26%) receiving a tunneled
femoral dialysis catheter developed deep venous throm-
bosis (DVT) of the ipsilateral lower extremity. All pre-
sented with unilateral lower extremity edema within
10 days after catheter placement, and were confirmed
by ultrasonography. Due to the absence of other options
for vascular access, all patients with DVT were treated
with anticoagulation therapy, and dialysis was continued
without removal of the catheter. Clinical improvement of
the DVT was observed in all patients after initiation of
anticoagulation. No patient had a bleeding complication
related to the anticoagulation.
DISCUSSION
A small subset of hemodialysis patients require place-
ment of a tunneled femoral vein catheter, after they have
exhausted all options for a permanent vascular access and
because bilateral central vein occlusion precludes place-
ment of a dialysis catheter in the chest. The present study
shows that about 2% of newly placed catheters at our
institution are placed in the femoral veins, similar to the
proportion reported by Zaleski et al [6]. These patients
usually have been on dialysis for a long period of time
(average 4.3 years) prior to requiring a tunneled femoral
catheter, and have had multiple failed permanent vascu-
lar accesses.
The primary patency of the femoral catheters was
significantly worse for tunneled femoral catheters,
compared with internal jugular catheters (Fig. 1). The
predominant reason for catheter exchange was a persis-
tent low blood flow (despite instillation of tPA); this was
true for both femoral and internal jugular catheters. Low
catheter blood flows may be caused by an intra-luminal
thrombus, a fibrin sheath, or kinking of the catheter [2].
Due to their location in the groin, and the flexion of the
hip when sitting, femoral catheters may be prone to kink-
ing. Unfortunately, it was not possible to determine the
etiology of malfunction of the individual catheters, as the
imaging studies to differentiate these causes were rarely
performed. The dose of tPA instilled was a constant 2 mg
per lumen, regardless of catheter size. The catheter vol-
ume of femoral catheters was 2.1 to 2.5 mL per port, com-
pared with 1.7 to 1.8 mL per port for the IJ catheters. Thus,
the tPA concentration instilled in the femoral catheters
could have been as much as 32% lower than that in the IJ
catheters. This difference could, in part, have reduced the
efficacy of the thrombolytic agent in femoral catheters.
The cumulative frequency of catheter-related bac-
teremia was similar for patients with femoral and internal
jugular dialysis catheters (Fig. 2). However, the likelihood
of catheter-related bacteremia is proportionate to the du-
ration of the catheter [2]. Because patients with femoral
catheters were more likely to have frequent exchanges
for dysfunction, this may have masked a higher likelihood
of bacteremia. It is also important to emphasize that we
routinely attempted an antibiotic lock protocol to salvage
the catheter in patients with catheter-related bacteremia.
Had we routinely replaced infected catheters [12], the
primary patency of femoral catheters would have been
even shorter.
We observed a high frequency of ipsilateral deep
vein thrombosis after placement of a tunneled femoral
catheter. The 25% rate of DVT in the current series
was somewhat higher than the 14% (3 of 21 patients)
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reported in a retrospective study by Zaleski et al [6].
Moreover, we only obtained a diagnostic ultrasound in
patients with a clinical suspicion for DVT. It is possible
that additional patients may have had subclinical DVT.
Presumably, the combination of reduction in blood flow
and local trauma to the vessel contributed to the forma-
tion of DVT in these patients. Fortunately, long-term anti-
coagulation therapy promoted resolution of the DVT and
allowed continued use of the femoral dialysis catheters.
Radiographic evidence of venous stenosis is present
in about 10% of patients with internal jugular dialysis
catheters [13]; some of these lesions may lead to venous
thrombosis.
CONCLUSION
Almost 2% of newly placed tunneled dialysis catheters
are in the femoral vein. The primary patency is substan-
tially lower for femoral than internal jugular catheters,
primarily due to persistent blood flow problems. The like-
lihood of getting a new vascular access (fistula or graft)
after placement of a tunneled femoral catheter is low.
Femoral catheters are frequently complicated by ipsilat-
eral lower extremity DVT, but this does not preclude con-
tinued use of the catheter for hemodialysis treatments.
Bacteremia is a common complication for both IJ and
femoral catheters.
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